3.52
+0.14(+4.14%)
Currency In USD
| Previous Close | 3.38 |
| Open | 3.39 |
| Day High | 3.57 |
| Day Low | 3.34 |
| 52-Week High | 4.88 |
| 52-Week Low | 0.21 |
| Volume | 496,123 |
| Average Volume | 2.32M |
| Market Cap | 346.3M |
| PE | -5.25 |
| EPS | -0.67 |
| Moving Average 50 Days | 3.71 |
| Moving Average 200 Days | 3.04 |
| Change | 0.14 |
If you invested $1000 in The Oncology Institute, Inc. (TOI) since IPO date, it would be worth $362.89 as of December 25, 2025 at a share price of $3.52. Whereas If you bought $1000 worth of The Oncology Institute, Inc. (TOI) shares 3 years ago, it would be worth $2,285.71 as of December 25, 2025 at a share price of $3.52.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
The Oncology Institute Announces Resignation of Board Member Gabe Ling
GlobeNewswire Inc.
Dec 01, 2025 1:30 PM GMT
CERRITOS, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Gabe Ling has resigned from the Board of Directors, ef
Ascertain and The Oncology Institute Co-Develop ‘Touchless’ AI Automation for Oncology Administration
GlobeNewswire Inc.
Nov 13, 2025 9:04 PM GMT
Partnership deployed touchless prior authorization system in eight weeks, achieving 95% reduction in authorization workloadCERRITOS, Calif. and NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Ascertain, a healthcare technology company pioneering agenti
The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call
GlobeNewswire Inc.
Oct 22, 2025 8:47 PM GMT
CERRITOS, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that the company will release its third quarter 2025 financial results after